Treatment Resistant Depression

Neurology·MeSH: Depressive Disorder, Treatment-Resistant

5 drugs in development·4 companies·7 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
COMP360 psilocybin treatment	COMPASS Pathways plc (CMPS)

Phase 2(3)

Drug	Company
nv-5138	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
nv-5138	X4 Pharmaceuticals, Inc (XFOR)
Psilocybin	COMPASS Pathways plc (CMPS)

Preclinical(1)

Drug	Company
individualized therapy for trd	Cyclerion Therapeutics, Inc. (CYCN)

BioSniper tracks 5 drugs in development for Treatment Resistant Depression across 4 companies.

There are 7 clinical trials targeting Treatment Resistant Depression tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.